UK markets close in 4 hours

Theriva Biologics, Inc. (SFY.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2140-0.0070 (-3.17%)
As of 08:20AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,036
-18,349
-19,685
-14,267
-10,043
Depreciation & amortisation
142
135
85
87
201
Deferred income taxes
-1,533
-1,640
-1,425
0
-
Stock-based compensation
586
552
475
416
350
Change in working capital
3,484
2,309
-806
709
-2,781
Accounts payable
93
-157
-385
-363
-1,429
Other working capital
-18,461
-19,198
-19,198
-12,904
-12,177
Other non-cash items
-1,910
-2,003
2,274
166
178
Net cash provided by operating activities
-18,267
-18,996
-19,082
-12,890
-12,168
Cash flows from investing activities
Investments in property, plant and equipment
-
-202
-116
-14
-9
Acquisitions, net
-
0
-4,280
0
-
Net cash used for investing activities
-194
-202
-4,396
-14
-9
Cash flows from financing activities
Debt repayment
-20
-75
-1,376
0
-
Common stock issued
-
2,219
0
65,960
3,359
Common stock repurchased
-
0
-288
0
-
Other financing activities
-
-1,519
-3,000
-
-
Net cash used provided by (used for) financing activities
680
625
-1,930
74,002
3,359
Net change in cash
-17,817
-18,606
-25,408
61,098
-8,818
Cash at beginning of period
36,176
41,885
67,325
6,227
15,045
Cash at end of period
18,395
23,279
41,885
67,325
6,227
Free cash flow
Operating cash flow
-18,267
-18,996
-19,082
-12,890
-12,168
Capital expenditure
-
-202
-116
-14
-9
Free cash flow
-18,461
-19,198
-19,198
-12,904
-12,177